S
TMCI icon

SignatureFD’s Treace Medical Concepts TMCI Stock Holding History

SignatureFD’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-762
Closed -$1.02K – 3636
2026
Q1 		$1.02K Sell
762
-754
-50% -$1.5K ﹤0.01% 3206
2025
Q4 		$3.71K Buy
1,516
+1,109
+272% +$4.82K ﹤0.01% 2796
2025
Q3 		$2.73K Hold
407
– – ﹤0.01% 2867
2025
Q2 		$2.39K Sell
407
-324
-44% -$2.11K ﹤0.01% 2818
2025
Q1 		$6.13K Buy
731
+78
+12% +$701 ﹤0.01% 2526
2024
Q4 		$4.86K Hold
653
– – ﹤0.01% 2616
2024
Q3 		$3.79K Buy
653
+379
+138% +$2.43K ﹤0.01% 2651
2024
Q2 		$1.82K Sell
274
-295
-52% -$2.38K ﹤0.01% 2782
2024
Q1 		$7.42K Hold
569
– – ﹤0.01% 2413
2023
Q4 		$7.25K Buy
569
+539
+1,797% +$5.45K ﹤0.01% 2391
2023
Q3 		$393 Buy
+30
New +$549 ﹤0.01% 3044
2023
Q1 		– Sell
-54
Closed -$1.24K – 3378
2022
Q4 		$1.24K Buy
+54
New +$1.24K ﹤0.01% 2927

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

SignatureFD's TMCI Position: Q2 2026 in Review

SignatureFD sold out of Treace Medical Concepts (TMCI) in Q2 2026, closing a stake of 762 shares — an estimated $1.02K sold.

SignatureFD first reported a position in TMCI in Q4 2022 and held it in 12 quarters. The position peaked at $7.42K in Q1 2024. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • SignatureFD reported no remaining Treace Medical Concepts position as of Q2 2026 after selling out during the quarter.
  • SignatureFD sold 762 Treace Medical Concepts shares in Q2 2026, an estimated $1.02K.
  • SignatureFD first reported a position in Treace Medical Concepts in Q4 2022 and held it in 12 quarters.
  • SignatureFD's Treace Medical Concepts position peaked at $7.42K in Q1 2024.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.